Pardoll DM - Search Results

1

PD-1+ Monocytes Mediate Cerebral Vasospasm Following Subarachnoid Hemorrhage.

Jackson CM, Choi J, Routkevitch D, Pant A, Saleh L, Ye X, Caplan JM, Huang J, McDougall CG, Pardoll DM, Brem H, Tamargo RJ, Lim M. Jackson CM, et al. Among authors: pardoll dm. Neurosurgery. 2021 Mar 15;88(4):855-863. doi: 10.1093/neuros/nyaa495. Neurosurgery. 2021. PMID: 33370819

2

Systemic and local paracrine cytokine therapies using transduced tumor cells are synergistic in treating intracranial tumors.

Thompson RC, Pardoll DM, Jaffee EM, Ewend MG, Thomas MC, Tyler BM, Brem H. Thompson RC, et al. Among authors: pardoll dm. J Immunother Emphasis Tumor Immunol. 1996 Nov;19(6):405-13. doi: 10.1097/00002371-199611000-00004. J Immunother Emphasis Tumor Immunol. 1996. PMID: 9041459

3

Inhibition of experimental vasospasm with anti-intercellular adhesion molecule-1 monoclonal antibody in rats.

Oshiro EM, Hoffman PA, Dietsch GN, Watts MC, Pardoll DM, Tamargo RJ. Oshiro EM, et al. Among authors: pardoll dm. Stroke. 1997 Oct;28(10):2031-7; discussion 2037-8. doi: 10.1161/01.str.28.10.2031. Stroke. 1997. PMID: 9341715

4

Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors.

Sampath P, Hanes J, DiMeco F, Tyler BM, Brat D, Pardoll DM, Brem H. Sampath P, et al. Among authors: pardoll dm. Cancer Res. 1999 May 1;59(9):2107-14. Cancer Res. 1999. PMID: 10232596

5

Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.

DiMeco F, Rhines LD, Hanes J, Tyler BM, Brat D, Torchiana E, Guarnieri M, Colombo MP, Pardoll DM, Finocchiaro G, Brem H, Olivi A. DiMeco F, et al. Among authors: pardoll dm. J Neurosurg. 2000 Mar;92(3):419-27. doi: 10.3171/jns.2000.92.3.0419. J Neurosurg. 2000. PMID: 10701528

6

Intracranial paracrine interleukin-2 therapy stimulates prolonged antitumor immunity that extends outside the central nervous system.

Ewend MG, Thompson RC, Anderson R, Sills AK, Staveley-O'Carroll K, Tyler BM, Hanes J, Brat D, Thomas M, Jaffee EM, Pardoll DM, Brem H. Ewend MG, et al. Among authors: pardoll dm. J Immunother. 2000 Jul-Aug;23(4):438-48. doi: 10.1097/00002371-200007000-00007. J Immunother. 2000. PMID: 10916753

7

Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors.

Hanes J, Sills A, Zhao Z, Suh KW, Tyler B, DiMeco F, Brat DJ, Choti MA, Leong KW, Pardoll DM, Brem H. Hanes J, et al. Among authors: pardoll dm. Pharm Res. 2001 Jul;18(7):899-906. doi: 10.1023/a:1010963307097. Pharm Res. 2001. PMID: 11496947

8

Inhibition of vasospasm with lymphocyte function-associated antigen-1 monoclonal antibody in a femoral artery model in rats.

Clatterbuck RE, Oshiro EM, Hoffman PA, Dietsch GN, Pardoll DM, Tamargo RJ. Clatterbuck RE, et al. Among authors: pardoll dm. J Neurosurg. 2002 Sep;97(3):676-82. doi: 10.3171/jns.2002.97.3.0676. J Neurosurg. 2002. PMID: 12296653

9

Gene therapy for experimental brain tumors using a xenogenic cell line engineered to secrete hIL-2.

Lesniak MS, Tyler BM, Pardoll DM, Brem H. Lesniak MS, et al. Among authors: pardoll dm. J Neurooncol. 2003 Aug-Sep;64(1-2):155-60. doi: 10.1007/BF02700030. J Neurooncol. 2003. PMID: 12952296

10

Dexamethasone mediated inhibition of local IL-2 immunotherapy is dose dependent in experimental brain tumors.

Lesniak MS, Gabikian P, Tyler BM, Pardoll DM, Brem H. Lesniak MS, et al. Among authors: pardoll dm. J Neurooncol. 2004 Oct;70(1):23-8. doi: 10.1023/b:neon.0000040821.50347.c5. J Neurooncol. 2004. PMID: 15527103

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters